2021 Archive

St. Jude scientists engage kindergarten students in interactive learning about infectious diseases while introducing them to careers in science.

Learn how discoveries in brain development are shaping brighter futures.

An experience treating a patient during her residency sparked her interest in neuro-oncology. Learn more about Emily Hanzlik, MD, and her clinical care philosophy.

Learn how survivorship differs between pediatric and adult cancer patients, and how St. Jude is providing unique support.

Discover how CAR T–cell therapy led to a growth spurt for both Alfonso and the immunotherapy program at St. Jude.

Learn how St. Jude is prioritizing psychosocial care in the treatment of pediatric catastrophic disease.

Clever engineering widens researchers’ view of the single-molecule scale.

Hear from Charles W.M. Roberts, MD, PhD, on why pediatric cancers are distinct from their adult counterparts – needing their own research and treatments.

The Global Platform for Access to Childhood Cancer Medicines is raising the profile of childhood cancer and how best to treat it in Ecuador.

Discover how a background in anthropology influences how clinical research scientist Julia Hanebrink, PhD, approaches qualitative research.

Kristin Lyons, director of Rehabilitation Services, and Jessica Sparrow, Lead Occupational Therapist, worked as part of a team of oncology rehabilitation providers from pediatric institutions across the country to co-author a recent Seminars in Oncology Nursing article, which provides a comprehensive overview of rehabilitation screening, assessment, and intervention for children with cancer.

Posterior fossa syndrome develops in some children following surgery for the brain tumor medulloblastoma. St. Jude research offers fresh insight into the mysterious syndrome and advice on how to avoid it.

The National Comprehensive Cancer Network recently published treatment guidelines for children diagnosed with nephroblastoma. Two St. Jude physicians collaborated on the project.

As cancer survivorship changes, new benchmarks must be set to redefine survivorship research and treatment success.

It’s essential to provide an accurate, science-based website for vaccine information. The St. Jude Global COVID-19 Working Group plans to provide accurate COVID-19 information, including answering questions and providing vaccine news as it emerges.

St. Jude Children’s Research Hospital is launching the largest strategic investment in its nearly 60-year history, committing $11.5 billion during the next six years to accelerate research and treatment globally for children with catastrophic diseases.

Cancer treatments can result in damage to the heart both during treatment and years following completion of therapy. As many cancer survivors are now living longer into adulthood, we’re gaining a better understanding of some of the late effects of cancer treatments that we weren’t able to observe before.

Scientists are learning more about antibody production in response to flu, including how they develop from helper T cells and monocytes.

The pandemic exposed shortcomings in health care. But this study revealed more than expected in this type of children’s treatment.

Tangie Thomas, MPH, is vice president of Clinical Trials Operations at St. Jude Children’s Research Hospital.